Eli Lilly (NYSE:LLY) announced today that the Egyptian Drug Authority approved insulin glargine manufactured in partnership ...

Egypt on Tuesday celebrated the launch of the first batch of locally produced insulin glargine, a much-needed medication for ...

The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly (LLY).

The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with ...

From life-changing medical advancements to colorful auroras, this year has been packed with incredible science. It was hard ...

Why pay $84,000 for a hepatitis C drug when you can make it at home? But such DIY chemistry raises safety concerns ...

HS-001 is a cell therapy commercialized by Novo Nordisk, with a leading Phase II program in Systolic Heart Failure.

Imagine a world where diabetes could be treated with a simple pill that essentially reprograms your body to produce insulin ...

A Cornerstone in Diabetes ManagementInsulin delivery devices market are innovative medical instruments designed to provide ...

As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according ...

Brian Thompson's murder is a grim symbol of a larger issue: the profit-driven healthcare system in the United States, where ...